Indeed, increased sensitivity to olaparib was observed in HNSCC cases with concurrent reduction in H3K36 methylation (e.g., due to NSD1 histone methyltransferase mutation) and increase in H3K27 trimethylation. The gene discussed is PRDM9; the disease is head and neck squamous cell carcinoma.